EUVIMEDEUVIMED entdecken
Crossref

Near-infrared Photoimmunotherapy Targeting High-risk Human Neuroblastoma Cells Expressing GD2

Hiroshi Nouso, Hiroshi Tazawa, Terutaka Tanimoto, Morimichi Tani, Hinako Watanabe, Takanori Oyama, Kazuhiro Noma, Shunsuke Kagawa, Hisataka Kobayashi, Takuo Noda, Shinji Kuroda, Toshiyoshi Fujiwara

Anticancer Research · 2026

DOI: 10.21873/anticanres.17921 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2026. Verfasst von Hiroshi Nouso und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan. Hauptthemen laut MEDLINE: Neuroblastoma, Gangliosides, Immunotherapy, Phototherapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeuroblastomaGangliosidesImmunotherapyPhototherapyInfrared RaysHumansAnimalsCell Line, TumorMiceXenograft Model Antitumor AssaysMice, NudeFemaleImmunoconjugates

Stichwörter der Autor:innen

GD2IR700Neuroblastomanear-infrared photoimmunotherapy

Substanzen

Gangliosidesganglioside, GD2Immunoconjugates

Autor:innen und Institutionen

  • Department of Pediatric Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
  • Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan; htazawa@md.okayama-u.ac.jp.
  • Center for Innovative Clinical Medicine, Okayama University Hospital, Okayama, Japan.
  • Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
  • Molecular Imaging Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, U.S.A.

Zitieren

APA

Nouso, H., Tazawa, H., Tanimoto, T., Tani, M., Watanabe, H., Oyama, T., Noma, K., Kagawa, S., Kobayashi, H., Noda, T., Kuroda, S., & Fujiwara, T. (2026). Near-infrared Photoimmunotherapy Targeting High-risk Human Neuroblastoma Cells Expressing GD2. Anticancer Research. https://doi.org/10.21873/anticanres.17921

Vancouver

Nouso H, Tazawa H, Tanimoto T, Tani M, Watanabe H, Oyama T, et al. Near-infrared Photoimmunotherapy Targeting High-risk Human Neuroblastoma Cells Expressing GD2. Anticancer Research. 2026. doi:10.21873/anticanres.17921

BibTeX
@article{Nouso2026,
  author = {Nouso, Hiroshi and Tazawa, Hiroshi and Tanimoto, Terutaka and Tani, Morimichi and Watanabe, Hinako and Oyama, Takanori and Noma, Kazuhiro and Kagawa, Shunsuke and Kobayashi, Hisataka and Noda, Takuo and Kuroda, Shinji and Fujiwara, Toshiyoshi},
  title = {Near-infrared Photoimmunotherapy Targeting High-risk Human Neuroblastoma Cells Expressing GD2},
  journal = {Anticancer Research},
  year = {2026},
  doi = {10.21873/anticanres.17921}
}
Kostenlos starten →